Lantern Pharma (LTRN) Prepaid Assets (2019 - 2026)
Lantern Pharma's (LTRN) quarterly Prepaid Assets came in at $734000.0 in Q1 2026, down 33.38% YoY from $1.1 million in Q1 2025, and up 7.32% on a QoQ basis from $683948.0 in Q4 2025.
Lantern Pharma (LTRN) Prepaid Assets (2019 - 2026) Analysis & Trends
Lantern Pharma (LTRN) has 8 years of Prepaid Assets data on file, last reported at $734000.0 in Q1 2026.
- Quarterly Prepaid Assets fell 33.38% year-over-year to $734000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $734000.0 (down 33.38% YoY) and the FY2025 annual result came in at $683948.0, down 44.62% from the prior year.
- Prepaid Assets advanced to $734000.0 in Q1 2026, from $683948.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $3.7 million in Q3 2022 to a low of $683948.0 in Q4 2025.
- A 5-year average of $2.0 million and a median of $2.0 million in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets jumped 120.27% — and 2024, when it tumbled 63.94%.
- Tracing LTRN's Prepaid Assets over 5 years: stood at $3.0 million in 2022, then tumbled by 31.7% to $2.0 million in 2023, then tumbled by 39.43% to $1.2 million in 2024, then sank by 44.62% to $683948.0 in 2025, then increased by 7.32% to $734000.0 in 2026.
- The last three Prepaid Assets figures came in at $734000.0 (Q1 2026), $683948.0 (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Lantern Pharma | 26.05 Mn | 26.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 734,000.00 |
| Dec 31, 2025 | 683,948.00 |
| Sep 30, 2025 | 1.10 Mn |
| Jun 30, 2025 | 1.30 Mn |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | 1.24 Mn |
| Sep 30, 2024 | 1.87 Mn |
| Jun 30, 2024 | 2.03 Mn |
| Mar 31, 2024 | 1.11 Mn |
| Dec 31, 2023 | 2.04 Mn |
| Sep 30, 2023 | 2.50 Mn |
| Jun 30, 2023 | 2.55 Mn |
| Mar 31, 2023 | 3.09 Mn |
| Dec 31, 2022 | 2.99 Mn |
| Sep 30, 2022 | 3.65 Mn |
| Jun 30, 2022 | 3.51 Mn |
| Mar 31, 2022 | 2.45 Mn |
| Dec 31, 2021 | 1.99 Mn |
| Sep 30, 2021 | 2.50 Mn |
| Jun 30, 2021 | 2.54 Mn |